Dr.Pradeep Pakalapati, Dr. Radhika Kasilanka, Dr.Triveni Pottasiri

Abstract

STUDY DESIGN : Prospective Observational Study

PURPOSE : To compare central retinal thickness (CRT) between eyes with proliferative diabetic retinopathy (PDR) patients treated with Intravitreal Ranibizumab and Ranibizumab with PRP

METHODS : 30 patients presented with Proliferative Diabetic Retinopathy were divided into two groups. Group A had 15 eyes who underwent Intravitreal Ranibizumab and Group B had 15 eyes who underwent Intravitreal Ranibizumab with Panretinal photocoagulation (PRP). Visual acuity and Central retinal thickness (CRT) were measured at baseline, 1 month and 2months and analyzed using Independent sample T test.

RESULTS: Significant difference is observed between two groups in Visual acuity (p<0.05) and Central Retinal thickness (p<0.05).

CONCLUSION: Treatment with Intravitreal Ranibizumab along with PRP showed better visual acuity but did not show much change regarding CRT when compared with Ranibizumab alone.